Volume 10 Number 11/12 November/December 2009
31 December 2009. Related: Editorial.
2009
12th European AIDS Society Conference (EACS) 11-14 November 2009, Cologne
31 December 2009. Related: Conference reports.
EACS releases three updated management guidelines (December 2009)
31 December 2009. Related: Conference reports, Guidelines.
11th International Workshop on Adverse Drug Reactions and Comorbidities in HIV (IWADR) 26-28 October 2009, Philadelphia
31 December 2009. Related: Conference reports.
Intermuscular tissue is decreased in HIV infection
31 December 2009. Related: Conference reports.
High incidence and risk factors for diabetes in French cohort
31 December 2009. Related: Conference reports.
Gender and race differences in lipodystrophy symptoms
31 December 2009. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Lipodystrophy is common in children from three European cohorts
31 December 2009. Related: Conference reports, Paediatric care.
Visceral adipose tissue returns to baseline after stopping therapeutic intervention with rHGH
31 December 2009. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Reduced levels of vitamin D in patients taking efavirenz
31 December 2009. Related: Conference reports.
Association between inflammation and sleep apnea in the MACS cohort
31 December 2009. Related: Conference reports.
Sports supplements impact on serum creatinine and eGFR markers of renal function
31 December 2009. Related: Conference reports.
9th AIDS Vaccine Conference 19-22 October 2009, Paris
31 December 2009. Related: Conference reports.
Thai HIV Vaccine Trial results presented and published
31 December 2009. Related: Conference reports, Vaccines and microbicides.
49th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 12-15 September 2009, San Francisco
31 December 2009. Related: Conference reports.
Smoking masks the long-term benefits of HAART on lung function
31 December 2009. Related: Conference reports.
Recent ARVs and the blood/brain barrier: CSF drug concentrations of darunavir/r and raltegravir
31 December 2009. Related: Conference reports, Antiretrovirals.
Raltegravir body composition study: 48-week DEXA results
31 December 2009. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Alcohol and marijuana may reduce drug levels of atazanavir and efavirenz
31 December 2009. Related: Conference reports, PK and drug interactions.
Other drug interaction studies at ICAAC
31 December 2009. Related: Conference reports, PK and drug interactions.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
30 December 2009. Related: Conference reports.
Early infant diagnosis
30 December 2009. Related: Conference reports, Paediatric care.
Difficulties with implementation
30 December 2009. Related: Conference reports, Paediatric care.
Infant outcomes
30 December 2009. Related: Conference reports, Paediatric care.
Improved neurodevelopmental outcomes
30 December 2009. Related: Conference reports, Paediatric care.
Treating children exposed to single dose nevirapine for PMTCT
30 December 2009. Related: Conference reports, Paediatric care.
Using a nevirapine-containing fixed dose combination in the CHAPAS trial
30 December 2009. Related: Conference reports, Paediatric care.
Once a day lamivudine and abacavir, and abacavir hypersensitivity in the ARROW trial
30 December 2009. Related: Conference reports, Paediatric care.
AIDS and mortality in South Africa
30 December 2009. Related: Treatment access.
Punishing success in tackling AIDS: funders retreat could wipe out health gains in HIV affected countries
30 December 2009. Related: Treatment access.
Tibotec issues Dear Doctor letter in Europe concerning severe etravirine reactions: three case reports
30 December 2009. Related: Treatment alerts, Antiretrovirals.
GSK and Pfizer launch joint HIV collaboration
30 December 2009. Related: Antiretrovirals.
Rate of accumulation of TAMS slow in patients continuing on failing AZT or d4T containing regimens
30 December 2009. Related: Drug resistance.
Reduced etravirine levels after direct switch from efavirenz
30 December 2009. Related: PK and drug interactions.
Gemfibrozil significantly reduced by lopinavir/r
30 December 2009. Related: PK and drug interactions.
FDA approval of generic ARVs
30 December 2009. Related: Treatment access.
Aging, HIV infection and the immune system
20 December 2009. Related: Basic science and immunology.
New neutralising antibodies discovered
20 December 2009. Related: Basic science and immunology.
The end of the line for IL-2
20 December 2009. Related: Basic science and immunology.
HIV, the brain and children
20 December 2009. Related: Paediatric care.
President Obama announces end to HIV-positive immigration ban in the US
20 December 2009. Related: Other news.
BHIVA Autumn Conference and CHIVA Parallel Sessions
20 December 2009. Related: On the web.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention abstracts
20 December 2009. Related: On the web.
WHO meeting: the impact of ARV treatment on prevention
20 December 2009. Related: On the web.
JAIDS Supplement: HIV scale-up and global health systems
20 December 2009. Related: On the web.
Returned to risk: deportation of HIV-positive migrants
20 December 2009. Related: On the web.
UK patient survey: you, your GP and HIV
20 December 2009. Related: On the web.
PLoS Medicine November 2009
20 December 2009. Related: On the web.
Volume 10 Number 11/12 November/December PDF
1 December 2009. Related: PDFs.
Volume 10 Number 9/10 September/October 2009
6 October 2009. Related: Editorial.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
5 October 2009. Related: Conference reports.
First results of new integrase compound: GSK1349572
5 October 2009. Related: Conference reports, Antiretrovirals.
Raltegravir in treatment-naive patients
5 October 2009. Related: Conference reports, Antiretrovirals.
Nevirapine vs atazanavir/ritonavir in treatment-naive patients: ARTEN study
5 October 2009. Related: Conference reports, Antiretrovirals.
Darunavir/r monotherapy studies
5 October 2009. Related: Conference reports, Antiretrovirals.
Maraviroc results similar to efavirenz when analysed using more sensitive tropism test
5 October 2009. Related: Conference reports, Antiretrovirals.
Lipid and metabolic changes with ARV combinations
5 October 2009. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Maximal suppression achieved with three drugs: no additional virological impact of raltegravir intensification
5 October 2009. Related: Conference reports, Antiretrovirals.
Tenofovir and renal safety
5 October 2009. Related: Conference reports, Side effects.
Time from seroconversion to treatment in Europe and Africa
5 October 2009. Related: Conference reports.
Pharmacokinetics of atazanavir/ritonavir during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Presentation with late stage HIV in women diagnosed during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Low transmission rates and favourable pregnancy outcomes reported in the DREAM study
5 October 2009. Related: Conference reports, Pregnancy.
Pregnancy rates and outcomes among women in the DART trial
5 October 2009. Related: Conference reports, Pregnancy.
Pregnancy outcomes in HAART exposed infants in Johannesburg
5 October 2009. Related: Conference reports, Paediatric care.